AZ’s Ticagrelor, Boehringer’s Triple Combo Fail to Clear MHLW Advisory Panel

A key advisory committee of the Ministry of Health, Labor and Welfare (MHLW) on May 27 put a hold on the approval of AstraZeneca’s oral antiplatelet agent ticagrelor and blocked the second attempt of Nippon Boehringer Ingelheim’s triple combo hypertension...read more